{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,21]],"date-time":"2026-10-21T15:06:25Z","timestamp":1792595185490,"version":"4.5.0"},"reference-count":25,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T00:00:00Z","timestamp":1775001600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T00:00:00Z","timestamp":1775001600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T00:00:00Z","timestamp":1775001600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T00:00:00Z","timestamp":1775001600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T00:00:00Z","timestamp":1775001600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T00:00:00Z","timestamp":1775001600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T00:00:00Z","timestamp":1775001600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Cancer Epidemiology"],"published-print":{"date-parts":[[2026,4]]},"DOI":"10.1016\/j.canep.2026.102987","type":"journal-article","created":{"date-parts":[[2026,1,16]],"date-time":"2026-01-16T17:12:20Z","timestamp":1768583540000},"page":"102987","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"special_numbering":"C","title":["Prostate cancer in Korea: Nationwide trends in prevalence and medication use during 2011\u20132021"],"prefix":"10.1016","volume":"101","author":[{"given":"Jaehee","family":"Jung","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hyunha","family":"Kang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eunjung","family":"Choo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hye-Young","family":"Kang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chang Wook","family":"Jeong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ha-Lim","family":"Jeon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hankil","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.canep.2026.102987_bib1","first-page":"229","article-title":"Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries","volume":"74","author":"Bray","year":"2024","journal-title":"CA Cancer J. Clin."},{"key":"10.1016\/j.canep.2026.102987_bib2","doi-asserted-by":"crossref","first-page":"312","DOI":"10.4143\/crt.2025.264","article-title":"Cancer statistics in Korea: Incidence, mortality, survival, and prevalence in 2022","volume":"57","author":"Park","year":"2025","journal-title":"Cancer Res. Treat."},{"key":"10.1016\/j.canep.2026.102987_bib3","doi-asserted-by":"crossref","first-page":"302","DOI":"10.1016\/j.eururo.2024.11.013","article-title":"Recent patterns and trends in global prostate cancer incidence and mortality: an update","volume":"87","author":"Schafer","year":"2025","journal-title":"Eur. Urol."},{"key":"10.1016\/j.canep.2026.102987_bib4","doi-asserted-by":"crossref","first-page":"175","DOI":"10.4111\/icu.20210405","article-title":"Incidence and mortality projections for major cancers among Korean men until 2034, with a focus on prostate cancer","volume":"63","author":"Pak","year":"2022","journal-title":"Invest. Clin. Urol."},{"key":"10.1016\/j.canep.2026.102987_bib5","doi-asserted-by":"crossref","first-page":"462","DOI":"10.1111\/j.1464-410X.2010.09334.x","article-title":"Management of prostate cancer in older men: Recommendations of a working group of the International Society of Geriatric Oncology","volume":"106","author":"Droz","year":"2010","journal-title":"BJU Int."},{"key":"10.1016\/j.canep.2026.102987_bib6","doi-asserted-by":"crossref","first-page":"899","DOI":"10.4143\/crt.2015.212","article-title":"Changing patterns of primary treatment in Korean men with prostate cancer over 10 years: a nationwide population based study","volume":"48","author":"Park","year":"2016","journal-title":"Cancer Res. Treat."},{"key":"10.1016\/j.canep.2026.102987_bib7","doi-asserted-by":"crossref","first-page":"331","DOI":"10.4143\/crt.2025.263","article-title":"Prediction of cancer incidence and mortality in Korea, 2025","volume":"57","author":"Jung","year":"2025","journal-title":"Cancer Res. Treat."},{"key":"10.1016\/j.canep.2026.102987_bib8","doi-asserted-by":"crossref","first-page":"709","DOI":"10.7326\/0003-4819-158-10-201305210-00005","article-title":"Effect of age, tumor risk, and comorbidity on competing risks for survival in a U.S. population-based cohort of men with prostate cancer","volume":"158","author":"Daskivich","year":"2013","journal-title":"Ann. Intern. Med."},{"key":"10.1016\/j.canep.2026.102987_bib9","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1016\/j.eururo.2014.07.020","article-title":"Impact of the site of metastases on survival in patients with metastatic prostate cancer","volume":"68","author":"Gandaglia","year":"2015","journal-title":"Eur. Urol."},{"key":"10.1016\/j.canep.2026.102987_bib10","doi-asserted-by":"crossref","first-page":"408","DOI":"10.1186\/s12913-019-4218-7","article-title":"National practice patterns and direct medical costs for prostate cancer in Korea across a 10 year period: a nationwide population-based study using a national health insurance database","volume":"19","author":"Kang","year":"2019","journal-title":"BMC Health Serv. Res."},{"key":"10.1016\/j.canep.2026.102987_bib11","doi-asserted-by":"crossref","first-page":"103","DOI":"10.12997\/jla.2022.11.2.103","article-title":"Understanding and utilizing claim data from the Korean National Health Insurance Service (NHIS) and health insurance review & assessment (HIRA) database for research","volume":"11","author":"Kyoung","year":"2022","journal-title":"J. Lipid Athereoscler"},{"key":"10.1016\/j.canep.2026.102987_bib12","doi-asserted-by":"crossref","first-page":"71","DOI":"10.4332\/KJHPA.2016.26.1.71","article-title":"Comorbidity adjustment in health insurance claim database","volume":"26","author":"Kim","year":"2016","journal-title":"Health Policy Manag."},{"key":"10.1016\/j.canep.2026.102987_bib13","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1016\/0021-9681(87)90171-8","article-title":"A new method of classifying prognostic comorbidity in longitudinal studies: development and validation","volume":"40","author":"Charlson","year":"1987","journal-title":"J. Chronic Dis."},{"key":"10.1016\/j.canep.2026.102987_bib14","unstructured":"Health Insurance Review and Assessment Service, Department of Drug Management, Details on the criteria and methods of drug reimbursement, July 2020 edition. https:\/\/repository.hira.or.kr\/handle\/2019.oak\/2478, 2020 (accessed 21 July 2025)."},{"key":"10.1016\/j.canep.2026.102987_bib15","doi-asserted-by":"crossref","first-page":"357","DOI":"10.4143\/crt.2024.253","article-title":"Cancer statistics in Korea: incidence, mortality, survival, and prevalence in 2021","volume":"56","author":"Park","year":"2024","journal-title":"Cancer Res. Treat."},{"key":"10.1016\/j.canep.2026.102987_bib16","doi-asserted-by":"crossref","first-page":"184","DOI":"10.4111\/icu.20210463","article-title":"The national-wide incidence of prostate-specific antigen testing trend for a decade in Korea by age group","volume":"63","author":"Ko","year":"2022","journal-title":"Invest. Clin. Urol."},{"key":"10.1016\/j.canep.2026.102987_bib17","doi-asserted-by":"crossref","DOI":"10.1136\/bmj-2023-077738","article-title":"Prostate cancer incidence and mortality in Europe and implications for screening activities: population based study","volume":"386","author":"Vaccarella","year":"2024","journal-title":"BMJ"},{"key":"10.1016\/j.canep.2026.102987_bib18","doi-asserted-by":"crossref","first-page":"4","DOI":"10.22465\/juo.244600220011","article-title":"Prostate-specific antigen-based prostate cancer screening: one for all or individualized for each race?\u2013a narrative review","volume":"22","author":"Jeong","year":"2024","journal-title":"J. Urol. Oncol."},{"key":"10.1016\/j.canep.2026.102987_bib19","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1016\/j.juro.2010.03.034","article-title":"Skeletal related events, bone metastasis and survival of prostate cancer: a population based cohort study in Denmark (1999\u20132007)","volume":"184","author":"N\u00f8rgaard","year":"2010","journal-title":"J. Urol."},{"key":"10.1016\/j.canep.2026.102987_bib20","doi-asserted-by":"crossref","DOI":"10.1155\/2023\/9161763","article-title":"Risk evaluation of bone metastases and a simple tool for detecting bone metastases in prostate cancer: a population-based study","volume":"2023","author":"Li","year":"2023","journal-title":"Comput. Math. Methods Med."},{"key":"10.1016\/j.canep.2026.102987_bib21","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1038\/s41391-022-00573-y","article-title":"Real-world use of bone modifying agents in metastatic, castration-resistant prostate cancer","volume":"26","author":"Mitchell","year":"2023","journal-title":"Prostate Cancer Prostatic Dis."},{"key":"10.1016\/j.canep.2026.102987_bib22","doi-asserted-by":"crossref","first-page":"1206","DOI":"10.3349\/ymj.2015.56.5.1206","article-title":"Prognostic impacts of metastatic site and pain on progression to castrate resistance and mortality in patients with metastatic prostate cancer","volume":"56","author":"Koo","year":"2015","journal-title":"Yonsei Med. J."},{"key":"10.1016\/j.canep.2026.102987_bib23","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-025-08279-6","article-title":"Risk of Alzheimer\u2019s disease and Parkinson\u2019s disease following androgen deprivation therapy in a real world nationwide cohort","volume":"15","author":"Jeon","year":"2025","journal-title":"Sci. Rep."},{"key":"10.1016\/j.canep.2026.102987_bib24","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/S0022-5347(05)67436-8","article-title":"Complete androgen blockade for prostate cancer: what went wrong?","volume":"164","author":"Laufer","year":"2000","journal-title":"J. Urol."},{"key":"10.1016\/j.canep.2026.102987_bib25","unstructured":"National Comprehensive Cancer Network. NCCN Clinical Practice Guidelines in Oncology: Prostate Cancer. Version 1.2016. https:\/\/www.nccn.org, 2016 (accessed 21 July 2025)."}],"container-title":["Cancer Epidemiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1877782126000020?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1877782126000020?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,29]],"date-time":"2026-05-29T23:38:01Z","timestamp":1780097881000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1877782126000020"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4]]},"references-count":25,"alternative-id":["S1877782126000020"],"URL":"https:\/\/doi.org\/10.1016\/j.canep.2026.102987","relation":{},"ISSN":["1877-7821"],"issn-type":[{"value":"1877-7821","type":"print"}],"subject":[],"published":{"date-parts":[[2026,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Prostate cancer in Korea: Nationwide trends in prevalence and medication use during 2011\u20132021","name":"articletitle","label":"Article Title"},{"value":"Cancer Epidemiology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.canep.2026.102987","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier Ltd. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"102987"}}